Micronoma Makes Key VP of Business Development Hire

Todd Czerwinski will oversee the development and execution of market access, strategic partnerships and sales as the company rolls out its groundbreaking early cancer diagnosis platform SAN DIEGO, May 24, 2022 — Micronoma, the first cancer detection biotech company...

Micronoma Wins Fourth Innovation Award This Year

Microbiome-driven liquid biopsy company draws international recognition for using innovative technology to enable early cancer detection and improve chances of survival SAN DIEGO, Nov. 3, 2021 /PRNewswire/ — Micronoma, the first cancer detection biotech company...

Micronoma Wins Bio-IT World Innovative Practices Award

Machine learning and microbiome-driven liquid biopsy technology draws recognition for improving early cancer diagnosis and chances of survival August 2, 2021 ­­­­– San Diego, Calif. Micronoma, the first cancer detection biotech company to diagnose cancer  at an early...

Micronoma Raises $3.5 Million in Convertible Note Financing

Investors more than double funding base for cancer microbiome diagnostic company to accelerate go-to-market timeline six months after seed February 17, 2021 — San Diego, Calif. Micronoma, the first cancer detection biotech company that utilizes signals from the...